Management of Thyroid Nodules and Differentiated Thyroid Cancer 2017
DOI: 10.1007/978-3-319-43618-0_21
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of Recurrent/Metastatic Thyroid Cancer with Radioactive Iodine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 56 publications
0
2
0
Order By: Relevance
“…1717 .In a study done by Isabelle et al, out of 43 patients who had undergone pulmonary metastasectomy predominantly for follicular carcinoma, showed an encouraging 10 year disease free survival of 84% in patients who underwent complete resection. This significantly declined to 62% on incomplete resection (p=0.013) 10 .…”
Section: Discussionmentioning
confidence: 92%
See 1 more Smart Citation
“…1717 .In a study done by Isabelle et al, out of 43 patients who had undergone pulmonary metastasectomy predominantly for follicular carcinoma, showed an encouraging 10 year disease free survival of 84% in patients who underwent complete resection. This significantly declined to 62% on incomplete resection (p=0.013) 10 .…”
Section: Discussionmentioning
confidence: 92%
“…I 131 therapy is the first choice of treatment for papillary and follicular thyroid cancers with distant metastasis, unless they lose the ability to trap iodine 9 . RAI (Radioactive iodine) therapy has shown to be effective in improving the disease free survival in patients diagnosed with locally advanced or metastatic diseases 10 .…”
Section: Introductionmentioning
confidence: 99%